Mahamaya Superspeciality Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 934.71%
- Profit Growth 771.68%
- Ebitda 15372.63%
- Net Worth 1025.80%
- Total Assets 63.07%
About Mahamaya Superspeciality
Mahamaya Superspeciality Private Limited (MSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2020 (Four years and two months 15 days old ). Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Ahluwalia and Ninder Chawla serve as directors at the Company.
Company Details
-
Location
Raipur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85120CT2020PTC010981
-
Company No.
010981
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Mahamaya Superspeciality?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Ahluwalia
|
Director | 26-Nov-2020 | Current |
|
Ninder Chawla
|
Director | 26-Nov-2020 | Current |
Financial Performance of Mahamaya Superspeciality.
Mahamaya Superspeciality Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 934.71% increase. The company also saw a substantial improvement in profitability, with a 771.68% increase in profit. The company's net worth Soared by an impressive increase of 1025.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahamaya Superspeciality?
Unlock access to Mahamaya Superspeciality's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Saag Multispeciality Private LimitedGaurav Ahluwalia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mahamaya Superspeciality?
Mahamaya Superspeciality has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahamaya Superspeciality, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahamaya Superspeciality's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.